TAG:
RCM
Negotiating Path Contracts with Hospitals, Third Parties
By Robert Michel | From the Volume XXXII, No. 2 – January 27, 2025 Issue
PART THREE OF A SERIES TO HELP ANATOMIC PATHOLOGY GROUPS THRIVE AND PROSPER during these challenging times, The Dark Report presents this third installment in a series that identifies clinical, operational, and financial strategies pathology groups…
Managing Denials and Appeals of Clinical Lab, Path Claims
By Robert Michel | From the Volume XXXI No. 15 – November 4, 2024 Issue
CEO SUMMARY: Based on a study of denials and appeals involving about 20 million lab test claims, the team at XiFin Inc. presents here their findings. They also provide recommendations on steps labs can take to reduce denials and win a greater proportion of appeals. IN RECENT…
Artificial Intelligence ‘Invades’ Pathology, Billing
By R. Lewis Dark | From the Volume XXIX, No. 3 – February 22, 2022 Issue
Predictions about the potential of artificial intelligence (AI) to transform nearly every area of healthcare are about to become reality. For the profession of laboratory medicine, AI is making speedy inroads into two areas. The first is anato…
Latest Lab Billing Trends Are AI, More Transparency
By Robert Michel | From the Volume XXIX, No. 3 – February 22, 2022 Issue
CEO SUMMARY: From predictive analytics to data curation to improved online payment options, the newest trends in billing allow clinical laboratories and anatomic pathology groups to boost their financial bottom lines without putting more pressure on patients. Technology is at the co…
XIFIN’s Acquisition of OmniSYS Will Unite Lab with Pharmacy
This is an excerpt of a 1,829-word article in the January 10, 2022 issue of THE DARK REPORT (TDR). The full article is available to members of The Dark Intelligence Group. CEO SUMMARY: XIFIN’s acquisition of OmniSys, a pharmacy technology company, is the latest evidence that …
XIFIN Buys OmniSYS, Bridges Lab to Pharmacy
By Robert Michel | From the Volume XXIX, No. 1 – January 10, 2022 Issue
CEO SUMMARY: XIFIN’s acquisition of pharmacy technology company OmniSYS is the latest evidence that retail pharmacies are preparing to become a new front door to healthcare for consumers. The deal allows XIFIN to bring clinical lab information about patients directly to pharmacist…
XIFIN to Open New Office in South Carolina for Lab Billing
By Robert Michel | From the Volume XXVIII, No. 9 – July 6, 2021 Issue
SINCE FEBRUARY, THE TOTAL NUMBER OF PEOPLE VACCINATED grew steadily even as the number of tests for COVID-19 declined sharply in the United States. But overall test volume has remained steady at 130% of pre-pandemic levels, said Brian Kemp, Vice President of Revenue Cycle Operations for XIFIN,…
How Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized